Artificial Intelligence

UI Health Pilot Program Uses Biosensors, Artificial Intelligence to Monitor Coronavirus Patients – NBC Chicago


It could
be the future of coronavirus care.

“The
technology is sophisticated enough that we’re going to see things that the
nurse can take care of before the patient feels the symptoms,” said Gary
Conkright, CEO of physIQ.

The Chicago-based company makes pinpointIQ, a system made up of wearable biosensors and artificial intelligence technology that tracks a patient’s physiological data. Together with the Chicago Medical Society, physIQ and UI Health are now teaming up to use the technology to help coronavirus patients.

“We
asked them to help us find a provider in the Chicago area that addresses the
underserved community, because they are being hit hardest,” Conkright said.

A majority of employees and patients at UI Health are minorities.

“They have some of the same risk factors that our primary service area has, and so hypertension, lung disease, such as asthma, said UIC’s Dr. Terry Vanden Hoek, Chief Medical Officer at UI Health and head of the Department of Emergency Medicine at the College of Medicine.

UI
Health is offering the physIQ technology for free to employees who test
positive for coronavirus and are in isolation at home. In addition, they are
also starting a pilot program for patients with
COVID-19 with risk factors such as obesity and heart or lung conditions and who
are isolating at home.

The pinpointIQ system will monitor the vital signs through a wearable biosensor that can detect changes in health status. The system then notifies advanced practice nurses who will monitor the data and alert the patient and a primary care provider if there are changes that could indicate worsening of a condition.

“With
an earlier warning, we can prevent the need to go to the intensive care unit to
be on a ventilator,” Vanden Hoek said.





READ SOURCE

This website uses cookies. By continuing to use this site, you accept our use of cookies.